Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Assessing Moderna (MRNA) Valuation After A Strong Yearly Rally And Ongoing Losses
Moderna and Merck's Cancer Combo Reduces Melanoma Spread Risk by 59% Over Five Years, ETPharma
Biotech Stocks To Research - May 24th - Zolmax
Biotech Stocks To Watch Now - May 23rd - Daily Political
North Dakota State Investment Board Invests $359,000 in Moderna, Inc. $MRNA - Daily Political
Insider Selling: Moderna (NASDAQ:MRNA) Director Sells $433,878.92 in Stock
Moderna Inc. (MRNA) - Insider Monkey
Moderna, Merck cancer combo cuts melanoma spread risk at five years
FDA to Hold Review Meeting for Moderna's Flu Vaccine | Morningstar
Moderna's (MRNA) Flu Vaccine Set for FDA Advisory Panel Review
FDA Plans Rare Advisory Hearing to Debate Moderna's Flu Shot
Forget Moderna: This Biotech Juggernaut Is a Way Better Buy Right Now
Promising Biotech Stocks To Consider - May 21st - Stock Observer
Immunovant Q4 Earnings Call Highlights - Daily Political
Moderna Inc at RBC Capital Markets Global Healthcare Conference Transcript
Hedge Fund and Insider Trading News: Bill Ackman, Ray Dalio, Warren Buffett, Viking Global, Darsana Capital Partners, Caxton Associates, Balyasny Asset Management, D1 Capital Partners, Republic Services Inc (RSG), Moderna Inc (MRNA), and More
Best Biotech Stocks To Add to Your Watchlist - May 18th
Insider Selling: Moderna (NASDAQ:MRNA) President Sells 53,336 Shares of Stock - Daily Political
Is Moderna (MRNA) Quietly Recasting Its mRNA Platform From Pandemic Play to Broad Vaccine Franchise?
Biotech Stocks To Research - May 17th - Stock Observer
Salesforce (CRM) Valuation Check As New AI Deals And Air Force Contract Lift Market Interest
Best Biotech Stocks To Keep An Eye On - May 15th - Daily Political
Therapeutics Stocks Q1 Recap: Benchmarking Halozyme Therapeutics (NASDAQ:HALO)
Top Biotech Stocks To Consider - May 14th - Daily Political
Best Biotech Stocks To Keep An Eye On - May 15th - Stock Observer
Israel to offer non-mRNA coronavirus vaccine
BMJ Senior Editor: COVID vaccines more likely to put you in hospital than keep you out
Top Biotech Stocks To Consider - May 14th - Zolmax
Salesforce (CRM), Moderna Partner to Unify Global Operations via Agentforce Life Sciences
Want To Invest With Impact? Here Are 4 Options To Consider
3 Cash-Heavy Stocks with Warning Signs
Moderna's TIME Ranking And Combo Vaccine Approval Reshape Growth Question
Staged claims and Israeli hoaxes: Debunking viral conspiracy theories about hantavirus
Best Biotech Stocks To Consider - May 13th - Stock Observer
Still 'many steps to do' in creating a hantavirus vaccine, experts say
Arbutus Reports First Quarter 2026 Financial Results and Provides Corporate Update
No cure, no approved vaccine, no antiviral: Why the Hantavirus threat is raising alarm again | Explained
Hantavirus fears put Moderna vaccine efforts in focus
Moderna Hantavirus Program Draws New Focus As Shares Outpace Targets
5 Insightful Analyst Questions From Moderna's Q1 Earnings Call
Health Care Down as Vaccine Bets Stall - Health Care Roundup | Morningstar
Moderna stock whipsaws as investors monitor hantavirus outbreak
Moderna Stock Is Surging on Hantavirus Threats. Its Chart Offers a Harsh Dose of Reality.
New Moderna Short Target After Hantavirus Vaccine News
Here's how much Moderna's stock has rallied off renewed focus on hantavirus research | Morningstar
Biotech Stocks Rally on Hantavirus Fears: Is the Surge Overdone?
Why Moderna Inc (MRNA) May Struggle to Outperform: A Look at Future Challenges
Moderna shares jump as it reveals it has been researching vaccines against hantaviruses
Moderna Extends Rally After Two More Cruise Ship Passengers Test Positive For Hantavirus
Moderna Says It's Researching a Hantavirus Vaccine. The Drugmaker's Stock Is Surging. - AOL
Moderna stock surges 22% in 2 days as investors monitor hantavirus outbreak
Moderna Stock Is Up 6% Today: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
Premarket Winners: Moderna (MRNA), Intel (INTC), and Micron (MU) Rally on Monday
Moderna stock extends gains on hantavirus research
Hantavirus cases spark surge in pharma, biotech stocks - here's why
Best Medical Stocks To Watch Today - May 11th - Daily Political
Moderna (MRNA) Shares Surge 8% on Hantavirus Vaccine Research
Moderna shares jump 8% after U.S. national tests positive for hantavirus
Moderna (MRNA) Sees Gains Amid Market Uncertainty
Top Biotech Stocks To Consider - May 10th - Stock Observer
Personalis, Inc. (NASDAQ:PSNL) Q1 2026 Earnings Call Transcript
Moderna (MRNA) Gains Attention Amid Rising Virus Concerns
MRNA Stock Alert: Moderna Surges on Hantavirus Vaccine Hopes
Moderna (MRNA) Advances Hantavirus Vaccine Development Amid Renewed Interest
Moderna (MRNA) Stock Jumps 16% Following Positive Flu Vaccine Results and Wall Street Upgrades
Moderna (NASDAQ:MRNA) Trading 12.6% Higher - Should You Buy?
Moderna Flags Work on Hantavirus Vaccines Before Cruise Outbreak
Investors Buy Large Volume of Moderna Call Options (NASDAQ:MRNA) - Zolmax
Brookline Capital Markets Forecasts Moderna FY2026 Earnings - Stock Observer
Moderna, Vir among early 2026 top infectious disease gainers | BioWorld
Is Wall Street Bullish or Bearish on Moderna Stock?
Paranoia, turmoil and backlash: Inside the FDA under Marty Makary
Moderna Shareholders OK Directors, Executive Pay Votes and Ernst & Young as 2026 Auditor at AGM - Stock Observer
Has The Market Rerated Moderna (MRNA) Too Quickly After Its Recent Share Price Surge?
Biotech Stocks To Add to Your Watchlist - May 6th - Daily Political
Assessing Moderna (MRNA) Valuation After Strong Q1 Results And New EU Vaccine And Oncology Milestones
Brookline Capital Markets Weighs in on Moderna Q2 Earnings - Stock Observer
Sigma Planning Corp Purchases New Holdings in Moderna, Inc. $MRNA - Stock Observer
Moderna updates on Cystic Fibrosis collaboration with Vertex Pharmaceuticals | Markets Insider
MRNA Maintained by RBC Capital -- Price Target Raised to $38.00
Abbas Hussain Sells 5,682 Shares of Moderna (NASDAQ:MRNA) Stock - Stock Observer
Pfizer vs Moderna: Only One Pharma Giant Is a Winner In The Post-Covid Era
Moderna (NASDAQ:MRNA) Posts Quarterly Earnings Results - Stock Observer
Moderna (MRNA) Loss Of US$2.8b Keeps Bearish Narratives In Focus
Moderna Q1 Earnings Call Highlights - Stock Observer
Moderna, Inc. (NASDAQ:MRNA) Q1 2026 Earnings Call Transcript
Vanguard Group Inc. Purchases 399,487 Shares of Moderna, Inc. $MRNA - Stock Observer
A Look At Moderna (MRNA) Valuation After Q1 2026 Earnings And New Vaccine Approvals
Moderna Inc (MRNA) Q1 2026 Earnings Call Highlights: Strategic Growth Amidst Legal Challenges
Q1 2026 Moderna Inc Earnings Call Transcript
Moderna, Inc. (NASDAQ:MRNA) Receives $33.87 Average PT from Analysts - Daily Political
Moderna price target raised to $49 from $43 at Goldman Sachs | Markets Insider
Moderna News
Markets.com Review 2026: Complete Account Opening Guide, Deposit, Withdrawal & Demo Test
S&P 500 Analysis: S&P 500 Trading Landscape Changes as Wall Street Reacts to Economic Data
Rivian Stock Price Prediction 2030: What South African Investors Need to Know about RIVN Stock?
AED/USD Exchange Rate Analysis: Why the AED is One of the Most Stable Currencies in Forex Right Now?
Latest news
Show more
UAE’s Explosive AI Growth: UAE Tops Global AI Adoption for Third Straight Quarter at 70.1% Usage Rate
Gold Price Today, May 27: XAU/USD Holds Steady Around $4,510 as Traders Eye Fed Signals and Iran Talks
Gold Price Today, May 26: XAU/USD Holds Near $4,540 as Markets Weigh Fed Signals
Fed Leadership Change: Kevin Warsh Takes Over Federal Reserve at Critical Economic Moment
Gold Price Today, May 25: XAU/USD Opens Near $4,523 After Friday's Close at $4,509 on US-Iran Developments
